Close filters
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
from to

Products from peptides&elephants GmbH

Filter
No results were found for the filter!
NEW
Delta Variant B.1.617.2 SCoV2 (Spike Glycoprotein) Delta Variant B.1.617.2 SCoV2 (Spike Glycoprotein)
This peptide pool with 27 peptides covers all mutations in the Spike Glycoprotein derived from the delta variant B.1.617.2 of SARS-CoV-2 which is prevalent in India and carries the L452R spike mutation, among others.
€230.00 *
NEW
Beta Variant B.1.351 SCoV2 (Spike Glycoprotein) Beta Variant B.1.351 SCoV2 (Spike Glycoprotein)
This peptide pool with 34 peptides covers all mutations in the Spike Glycoprotein derived from the beta variant B.1.351 of SARS-CoV-2 which emerged in South Africa in December 2020 and reduces the effectiveness of some vaccines.
€230.00 *
NEW
Gamma Variant P.1 SCoV2 (Spike Glycoprotein) Gamma Variant P.1 SCoV2 (Spike Glycoprotein)
This peptide pool with 36 peptides covers all mutations in the Spike Glycoprotein derived from the gamma variant P.1 of SARS-CoV-2 which emerged in Brazil in late 2020 and has similar mutations to the beta variant B.1.351.
€230.00 *
NEW
Alpha Variant B.1.1.7 SCoV2 (Spike Glycoprotein) Alpha Variant B.1.1.7 SCoV2 (Spike Glycoprotein)
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the alpha variant B.1.1.7 of SARS-CoV-2 which emerged in Britain in December 2020 and is thought to be roughly 50 percent more infectious and...
€230.00 *
NEW
CMV Sub Peptide Pool (>95% HPLC) CMV Sub Peptide Pool (>95% HPLC)
This pool consists of 14 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from cytomegalovirus (CMV).
€63.25 *
NEW
HBV Sub Peptide Pool (>95% HPLC) HBV Sub Peptide Pool (>95% HPLC)
This pool consists of 9 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Hepatitis B virus (HBV).
€63.25 *
NEW
RSV Sub Peptide Pool (>95% HPLC) RSV Sub Peptide Pool (>95% HPLC)
This pool consists of 28 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Respiratory Syncytial Virus (RSV).
€63.25 *
NEW
EBV LMP-2 340-349 mutant (HLA-A*11:01) 348T EBV LMP-2 340-349 mutant (HLA-A*11:01) 348T
SSCSSCPLTK is a linear mutated peptidic epitope (epitope ID60930) studied as part of Latent membrane protein 2 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays...
From €57.50 *
Details
NEW
Proinsulin 90-104 Proinsulin 90-104
This is a Proinsulin-derived peptide of GIVEQCCTSICSLYQ sequence covering 90-104 and DRB1*04:01 molecule.
From €115.00 *
Details
NEW
Omicron Variant B.1.1.529 SCoV2 (Spike Glycoprotein) Omicron Variant B.1.1.529 SCoV2 (Spike...
This peptide pool with 80 peptides covers all mutations in the Spike Glycoprotein derived from the omicron variant B.1.1.529 of SARS-CoV-2 which is prevalent in south africa.
€230.00 *
NEW
Omicron full length B.1.1.529 SCoV2 (Spike Glycoprotein) Omicron full length B.1.1.529 SCoV2 (Spike...
This peptide pool covers the whole spike glycoprotein with all mutations of the new omicron variant of SARS-CoV-2 (315 peptides, delivered in two subpools of 158 & 157 peptides) .
€805.00 *
NEW
Omicron Variant B.1.1.529 SCoV2 wt (Spike Glycoprotein) Omicron Variant B.1.1.529 SCoV2 wt (Spike...
This pool consists of 82 peptides of the spike protein and represent the wildtype peptides to the mutations of the new omicron variant of SARS-CoV-2 (B.1.1.529) and is therefore recommended as a reference.
€230.00 *
[Phe17] - Apelin [Phe17] - Apelin
Apelin has been found to be expressed in the spinal cord and the human brain and when performing immunohistochemistry it was observed that apelin-17 is significantly expressed in the human heart, brain, lungs and endothelial cells.
From €115.00 *
Details
[beta]-Casomorphin (1-7), bovine [beta]-Casomorphin (1-7), bovine
#
From €57.50 *
Details
Trp2 180-188 Trp2 180-188
This peptide is derived from tyrosinase-related protein 2 (TRP-2) residues 180-188. TRP-2 peptide, also named L-dopachrome tautomerase, H-2KB or DCT, belongs to the melanocyte differentiation antigens and has been implicated as a target...
From €57.50 *
Details
Influenza A virus HA 306-318 (DRB1*01:01) Influenza A virus HA 306-318 (DRB1*01:01)
Antigen Peptide Influenza PKYVKQNTLKLAT for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 1000-1008 (HLA-A*02:01) SARS-CoV-2 Surface GP A2 1000-1008 (HLA-A*02:01)
YLQPRTFLL is an antigen-specific SARS-CoV-2 peptide
From €92.00 *
Details
ACTH (1-39) (human) ACTH (1-39) (human)
ACTH (1-39), human is a synthetic peptide corresponding to the first 39 amino acids of human ACTH/adrenocorticotropin which is the major regulator of adrenal cortex function. ACTH stimulates the synthesis of steroidal hormones.
From €241.50 *
Details
ACTH (18-39) (human) ACTH (18-39) (human)
Adrenocorticotropic hormone (ACTH) (18-39) is a C-terminal peptide fragment of ACTH, a peptide hormone found in the brain that is involved in the biological stress response. ACTH is produced in the anterior pituitary gland upon...
From €172.50 *
Details
gp100 170-178 (HLA-A*24:02) gp100 170-178 (HLA-A*24:02)
#
From €57.50 *
Details
MBP (54-72) human MBP (54-72) human
MBP (54-72) human - SHHAARTTHYGSLPQKSQR represents a short peptide sequence of the protein lipid part of the myelin sheath. Such proteins are obviously targets of the immune defense in multiple sclerosis.
From €195.50 *
Details
MOG 97-108 MOG 97-108
Myelin oligodendrocyte glycoprotein (MOG)97 - 108, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
Fibromodulin F4 226-235 (HLA-A*02:01) Fibromodulin F4 226-235 (HLA-A*02:01)
YLLDLSYNHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from tumor-associated antigen Fibromodulin F4 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in...
From €57.50 *
Details
LCMV GP (33-41) (H-2 Db) LCMV GP (33-41) (H-2 Db)
Antigen Peptide Pre-glycoprotein polyprotein H-2 Db (KAVYNFATM) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. LCMV gp33 peptide KAVYNFATM (H-2 Db) is a single...
From €57.50 *
Details
FLAG FLAG
This epitope tag is a short hydrophilic, highly charged peptide. It is the most widely used epitope tag employed in structural and functional studies of proteins.
From €92.00 *
Details
MOG 40-54 MOG 40-54
Myelin oligodendrocyte glycoprotein (MOG) 40-54, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
MOG 40-55 MOG 40-55
Myelin oligodendrocyte glycoprotein (MOG) 40-55, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
MOG 94 - 110, human MOG 94 - 110, human
Myelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €195.50 *
Details
MBP (63–81) MBP (63–81)
#
From €149.50 *
Details
EBV EBNA-1 407-417 mutant (HLA-B*35:01) 410A EBV EBNA-1 407-417 mutant (HLA-B*35:01) 410A
EBNA1-derived peptide of HPVAEADYFEY covering 407-417 and B*35:08 molecule. HPVAEADYFEY is a linear peptidic epitope (epitope ID 227777) studied as part of Epstein-Barr nuclear antigen 1 from Human herpesvirus 4 (Epstein Barr virus)....
From €92.00 *
Details
EBV EBNA-1 407-417 mutant (HLA-B*35:08) 411D EBV EBNA-1 407-417 mutant (HLA-B*35:08) 411D
EBV EBNA1-derived peptide of HPVGDADYFEY covering 407-417 and B*35:08 molecule. HPVGDADYFEY is a linear peptidic epitope (epitope ID 24525) studied as part of Epstein-Barr nuclear antigen 1 from Human herpesvirus 4 (Epstein Barr virus)....
From €92.00 *
Details
gp100 17-25 (HLA-A*03:01) gp100 17-25 (HLA-A*03:01)
#
From €57.50 *
Details
LCMV envelope gp 10-18 (HLA-A*02:01) LCMV envelope gp 10-18 (HLA-A*02:01)
ALPHIIDEV is a linear peptidic epitope (epitope ID2814) studied as part of Pre-glycoprotein polyprotein GP complex from Lymphocytic choriomeningitis mammarenavirus. This epitope has been studied for immune reactivity, tested in T cell...
From €57.50 *
Details
HIV env 816-825 (HLA-A*02:01) HIV env 816-825 (HLA-A*02:01)
Correlation between HLA class I and spontaneous control of HIV-1 was significant for 7-8 epitopes when 341 chronic, HIV-infected subjects, divided into controllers and non-controllers, were tested for EliSpot responses to 257 optimally...
From €57.50 *
Details
HIV Env 586-593 (HLA-B*08:01) HIV Env 586-593 (HLA-B*08:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed Env-derived peptide of YLKDQQLL sequence covering 586-593 and...
From €57.50 *
Details
RSV MP 229-237 (HLA-A*01:01) RSV MP 229-237 (HLA-A*01:01)
#
From €57.50 *
Details
RSV Fusion protein 540-548 (HLA-A*02:01) RSV Fusion protein 540-548 (HLA-A*02:01)
#
From €57.50 *
Details
Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike Glycoprotein) Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike...
This peptide pool with 14 peptides covers all mutations in the Spike Glycoprotein derived from the epsilon variant B.1.427/B.1.429 of SARS-CoV-2 which emerged in the US in March 2020.
€230.00 *
Zeta Variant P.2 SCoV2 (Spike Glycoprotein) Zeta Variant P.2 SCoV2 (Spike Glycoprotein)
This peptide pool with 12 peptides covers all mutations in the Spike Glycoprotein derived from the zeta variant P.2 of SARS-CoV-2 which emerged in Brazil in April 2020.
€230.00 *
Eta Variant B.1.525 SCoV2 (Spike Glycoprotein) Eta Variant B.1.525 SCoV2 (Spike Glycoprotein)
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the eta variant B.1.525 of SARS-CoV-2 which emerged in Angola in December 2020.
€230.00 *
Theta Variant P.3 SCoV2 (Spike Glycoprotein) Theta Variant P.3 SCoV2 (Spike Glycoprotein)
This peptide pool with 30 peptides covers all mutations in the Spike Glycoprotein derived from the theta variant P.3 of SARS-CoV-2 which emerged in the Philippines in January 2021.
€230.00 *
Iota Variant B.1.526 SCoV2 (Spike Glycoprotein) Iota Variant B.1.526 SCoV2 (Spike Glycoprotein)
This peptide pool with 21 peptides covers all mutations in the Spike Glycoprotein derived from the iota variant B.1.526 of SARS-CoV-2 which emerged in the US in November 2020.
€230.00 *
Kappa Variant B.1.617.1 SCoV2 (Spike Glycoprotein) Kappa Variant B.1.617.1 SCoV2 (Spike Glycoprotein)
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the kappa variant B.1.617.1 of SARS-CoV-2 which emerged in India in October 2020.
€230.00 *
Lambda Variant C.37 SCoV2 (Spike Glycoprotein) Lambda Variant C.37 SCoV2 (Spike Glycoprotein)
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the lambda variant C.37 of SARS-CoV-2 which emerged in Peru in August 2020.
€230.00 *
HIV-1 Nef 134-143 (HLA-A*24:02) HIV-1 Nef 134-143 (HLA-A*24:02)
#
From €57.50 *
Details
SARS-CoV-2 (Spike Glycoprotein) SARS-CoV-2 (Spike Glycoprotein)
Pool of 316 overlapping peptides (delivered in two subpools of 158 & 158 peptides) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P0DTC2) of SARS-CoV-2 (Severe Acute Respiratory...
€575.00 *
HCV core 35-44 (HLA-A*02:01) HCV core 35-44 (HLA-A*02:01)
YLLPRRGPRL is a linear peptidic epitope (epitope ID74798) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays
From €57.50 *
Details
Influenza A (H1N1) HA Influenza A (H1N1) HA
Pool of 139 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Hemagglutinin (UniProt ID: C3W5S1) of Influenza A virus (strain swl A/California/04/2009 H1N1)
€230.00 *
HHV1 Envelope Glycoprotein D HHV1 Envelope Glycoprotein D
Pool of 96 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope glycoprotein D (UniProt ID: P57083) of Human herpesvirus 1 (strain Patton) (HHV-1) (Human herpes simplex virus 1)
€172.50 *
Candida (MP65) Candida (MP65)
Pool of 92 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Mannoprotein MP65 (UniProt ID: Q9HEP1) of Candida albicans (Yeast) for T cell assays (e.g. ELISPOT)
€172.50 *
SARS-CoV-2 (NS7a) SARS-CoV-2 (NS7a)
Pool of 28 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Non-structural protein 7A (UniProt: P0DTC7) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell...
€172.50 *
SARS-CoV-2 (ORF9c) SARS-CoV-2 (ORF9c)
Pool of 16 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Uncharacterized ORF9c protein (UniProt: P0DTD3) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays...
€172.50 *
SARS-CoV-2 (M-Protein) SARS-CoV-2 (M-Protein)
Pool of 53 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane protein (UniProt: P0DTC5) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)
€201.25 *
SARS-CoV-2 (VEMP) SARS-CoV-2 (VEMP)
Pool of 16 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope small membrane protein (UniProt: P0DTC4) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays...
€172.50 *
SARS-CoV-2 (ORF9b) SARS-CoV-2 (ORF9b)
Pool of 22 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Protein 9b (UniProt: P0DTD2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)
€172.50 *
SARS-CoV-2 (ORF10) SARS-CoV-2 (ORF10)
Pool of 7 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire ORF10 Protein (UniProt: A0A663DJA2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g....
€172.50 *
SARS-CoV-2 (NS8) SARS-CoV-2 (NS8)
Pool of 28 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Non-structural protein 8 (UniProt: P0DTC8) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell...
€172.50 *
SARS-CoV-2 (NS7b) SARS-CoV-2 (NS7b)
Pool of 8 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Non-structural Protein 7b (UniProt: P0DTD8) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell...
€172.50 *
SARS-CoV-2 (NS6) SARS-CoV-2 (NS6)
Pool of 13 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Non-Structural protein 6 (UniProt: P0DTC6) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell...
€115.00 * €150.00 *
SARS-CoV-2 (N-Protein) SARS-CoV-2 (N-Protein)
Pool of 102 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein (UniProt: P0DTC9) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
€230.00 *
SARS-CoV-2 (ORF3a) SARS-CoV-2 (ORF3a)
Pool of 66 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein ORF3a (UniProt: P0DTC3) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
€230.00 *
HCoV-229E (Spike Glycoprotein) HCoV-229E (Spike Glycoprotein)
Pool of 291 overlapping peptides (delivered in two subpools of 146 & 145 peptides) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P15423) of Human coronavirus 229E (HCoV-229E) for T cell...
€517.50 *
HCoV-OC43 (Spike Glycoprotein) HCoV-OC43 (Spike Glycoprotein)
Pool of 336 overlapping peptides (delivered in two subpools of 168 & 168 peptides) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P36334) of Human coronavirus OC43 (HCoV-OC43) for T cell...
€517.50 *
HCoV-229E Nucleoprotein N HCoV-229E Nucleoprotein N
Pool of 95 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein (UniProt ID: P15130) of Human coronavirus 229E (HCoV-229E)
€230.00 *
HCoV-229E Membrane protein M HCoV-229E Membrane protein M
Pool of 54 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane protein (UniProt ID: P15422) of Human coronavirus 229E (HCoV-229E)
€230.00 *
HCoV-HKU1 (isolate N5) Nucleoprotein N HCoV-HKU1 (isolate N5) Nucleoprotein N
Pool of 108 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein (UniProt ID: Q0ZME3) of Human coronavirus HKU1 (isolate N5)
€230.00 *
HCoV-HKU1 (isolate N5) Membrane protein M HCoV-HKU1 (isolate N5) Membrane protein M
Pool of 53 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane protein (UniProt ID: Q0ZME4) of Human coronavirus HKU1 (isolate N5)
€230.00 *
HCoV-NL63 Nucleoprotein N HCoV-NL63 Nucleoprotein N
Pool of 92 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein (UniProt ID: Q6Q1R8) of Human coronavirus NL63 (HCoV-NL63)
€230.00 *
HCoV-NL63 Membrane protein M HCoV-NL63 Membrane protein M
Pool of 54 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane protein (UniProt ID: Q0ZME4) of Human coronavirus NL63 (HCoV-NL63)
€230.00 *
HCoV-OC43 Nucleoprotein N HCoV-OC43 Nucleoprotein N
Pool of 110 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein (UniProt ID: P33469) of Human coronavirus OC43 (HCoV-OC43)
€230.00 *
HCoV-OC43 Membrane protein M HCoV-OC43 Membrane protein M
Pool of 55 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane protein (UniProt ID: Q01455) of Human coronavirus OC43 (HCoV-OC43)
€230.00 *
MuLV p15E (H-2Kb ) MuLV p15E (H-2Kb )
KSPWFTTL is a linear peptidic epitope (epitope ID33474) studied as part of Envelope glycoprotein from Murine leukemia virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
From €57.50 *
Details
[Ala8] - Humanin, [Ala8] - HN, Shna [Ala8] - Humanin, [Ala8] - HN, Shna
Protection activity of humanin (HN) against neuronal cell death is abrogated in this peptide, where Cys8 is substituted by Ala.
From €92.00 *
Details
VZV (IE63) Peptide Pool VZV (IE63) Peptide Pool
Pool of 67 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Transcriptional transactivator IE63 (UniProt ID: Q77NN7-1) of Varicella-zoster virus (strain Oka vaccine) for T cell assays
€172.50 *
VZV (gE) Peptide Pool VZV (gE) Peptide Pool
Pool of 153 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope glycoprotein E (UniProt ID: P09259) of Varicella-zoster virus (strain Dumas) (HHV-3) (Human herpesvirus 3).
€195.50 *
gp100 (pmel17) 476-485 (HLA-A*02:01) gp100 (pmel17) 476-485 (HLA-A*02:01)
#
From €57.50 *
Details
GPC3 298-306 (HLA-A*24:02) GPC3 298-306 (HLA-A*24:02)
#
From €57.50 *
Details
GPC3 144-152 (HLA-A*02:01) GPC3 144-152 (HLA-A*02:01)
#
From €57.50 *
Details
EZH2 666-674 (HLA-A*02:01) EZH2 666-674 (HLA-A*02:01)
#
From €57.50 *
Details
EphA2 883-891 (HLA-A*02:01) EphA2 883-891 (HLA-A*02:01)
#
From €57.50 *
Details
EBV LMP2 419-427 (HLA-A*24:02) EBV LMP2 419-427 (HLA-A*24:02)
#
From €57.50 *
Details
EBV EBNA3B 416-424 (HLA-A*11:01; HLA-A*68:01) EBV EBNA3B 416-424 (HLA-A*11:01; HLA-A*68:01)
From €57.50 *
Details
CD33 65-73 mutant (HLA-A*02:01) 65Y, 66L CD33 65-73 mutant (HLA-A*02:01) 65Y, 66L
YLISGDSPV is a linear peptidic epitope (epitope ID74719), tested in T cell assays and MHC ligand assay
From €57.50 *
Details
BRAF 594-601 mutant (HLA-B*27:05) 600V BRAF 594-601 mutant (HLA-B*27:05) 600V
#
From €57.50 *
Details
BRAF 594-601 mutant (HLA-B*27:05) 600E BRAF 594-601 mutant (HLA-B*27:05) 600E
Tis peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed BRAF (600E)-derived peptide of GRFGLATEK sequence covering 594-601...
From €57.50 *
Details
BCR/ABL 210 kD fusion protein 21-29 (HLA-A*03:01) BCR/ABL 210 kD fusion protein 21-29 (HLA-A*03:01)
From €57.50 *
Details
MOG 35-52 MOG 35-52
Myelin oligodendrocyte glycoprotein (MOG) 35-52, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €195.50 *
Details
MOG 38-53 MOG 38-53
Myelin oligodendrocyte glycoprotein (MOG) 38-53, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
MOG 37–54, mouse, rat MOG 37–54, mouse, rat
Myelin oligodendrocyte glycoprotein (MOG) 37–54, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
MOG 35 - 53 MOG 35 - 53
Myelin oligodendrocyte glycoprotein (MOG) 35-53, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €195.50 *
Details
MOG 35 - 51 MOG 35 - 51
Myelin oligodendrocyte glycoprotein (MOG) 35-51, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €195.50 *
Details
MOG 27 - 50, human MOG 27 - 50, human
Myelin oligodendrocyte glycoprotein (MOG) 27-50, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €264.50 *
Details
MOG 14 - 39, human MOG 14 - 39, human
Myelin oligodendrocyte glycoprotein (MOG) 14 - 39, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €264.50 *
Details
MOG 8 - 22, rat MOG 8 - 22, rat
Myelin oligodendrocyte glycoprotein (MOG) 8 - 22, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
MOG 8 - 21 MOG 8 - 21
Myelin oligodendrocyte glycoprotein (MOG) 8 - 21, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
MOG 1 - 26, human MOG 1 - 26, human
Myelin oligodendrocyte glycoprotein (MOG) 1 - 26, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €264.50 *
Details
MOG 1 - 21, rat MOG 1 - 21, rat
Myelin oligodendrocyte glycoprotein (MOG) 1 - 21, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €241.50 *
Details
CyLoP-1 CyLoP-1
CyLoP-1 is a cysteine-rich cell-penetrating peptide derived from nuclear localization sequence of snake toxin, crotamine. The peptide has shown cytoplasmic uptake in mammalian cells at lower concentrations. In the present study, the...
From €138.00 *
Details
HIV TAT (47-57) HIV TAT (47-57)
TAT protein is the nuclear transcriptional activator of viral gene expression in HIV proliferation. The TAT peptide corresponds to the polycationic aa47-57 region of TAT protein. TAT peptide is a cell-penetrating peptide (CPP) used to...
From €74.75 *
Details
HIV TAT (48-60) HIV TAT (48-60)
Peptide derived from the HIV transactivator of transcription protein. TAT is a cationic cell-penetrating peptide.
From €86.25 *
Details
Arg9_Amide Arg9_Amide
This is a peptide comprising of 9 arginine residues. It has been shown that poly-Arg peptides composed of 9 arginine residues are able to efficiently translocate across cells. It has also been shown in model systems that Arg-9...
From €57.50 *
Details
Arg9 Arg9
This is a peptide comprising of 9 arginine residues. It has been shown that poly-Arg peptides composed of 9 arginine residues are able to efficiently translocate across cells. It has also been shown in model systems that Arg-9...
From €57.50 *
Details
LCMV GP 64-80 LCMV GP 64-80
#
From €149.50 *
Details
PLP (178-191) PLP (178-191)
NTWTTCQSIAFPSK represents a short peptide sequence of the protein lipid portion of the myelin sheath. Proteins of the myelin sheath are obvious targets of immune defense in multiple sclerosis.
From €97.75 *
Details
PLP (139-151) PLP (139-151)
This is amino acid residue 139 to 151 of myelin proteolipid protein (PLP). This peptide is used to induce relapsing-remitting (RR)-EAE model.
From €97.75 *
Details
MBP (1-11) human MBP (1-11) human
MBP (1-11) human - ASQKRPSQRHG represents a short peptide sequence of the protein lipid part of the myelin sheath. Such proteins are obviously targets of the immune defense in multiple sclerosis.
From €57.50 *
Details
MOG 91 - 108, rat MOG 91 - 108, rat
Myelin oligodendrocyte glycoprotein (MOG) 91 - 108, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €195.50 *
Details
MOG 183-191 MOG 183-191
Myelin oligodendrocyte glycoprotein (MOG) 183-191, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €57.50 *
Details
MOG 92-106 MOG 92-106
Myelin oligodendrocyte glycoprotein (MOG)92-106, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
MOG 35-55 human MOG 35-55 human
Myelin oligodendrocyte glycoprotein (MOG) 35-55, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
Melan - A, MART 1 (26 - 35) Melan - A, MART 1 (26 - 35)
This native Melan-A (26-35) decapeptide is an immunodominant antigen from melanocyte/melanoma (Melan-A/MART) protein that is more efficiently recognized by tumor-infiltrating lymphocytes (TILs) of melanoma patients than the Melan-A...
From €57.50 *
Details
MAGE-A3 271-279 (HLA-A*02:01) MAGE-A3 271-279 (HLA-A*02:01)
FLWGPRALV is a linear peptidic epitope (epitope ID16970) studied as part of Melanoma-associated antigen 3 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
From €57.50 *
Details
HCV NS5b 2594-2602 mutant (HLA-A*02:01) 2600S HCV NS5b 2594-2602 mutant (HLA-A*02:01) 2600S
#
From €57.50 *
Details
NS5B 2936-2944 (HLA-B*27:05) NS5B 2936-2944 (HLA-B*27:05)
#
From €57.50 *
Details
Human HLA-A*02, A*24 leader 3-11 (HLA-A*02) Human HLA-A*02, A*24 leader 3-11 (HLA-A*02)
HLA-A leader 3-11-derived peptide of VMAPRTLVL sequence covering 3-11 and HLA-E*01:03 molecule. VMAPRTLVL is a linear peptidic epitope (epitope ID69922) studied as part of HLA class I histocompatibility antigen, A-68 alpha chain from...
From €57.50 *
Details
Larazotide (AT-1001) Larazotide (AT-1001)
Larazotide (INN; also known as AT-1001; formulated as the salt with acetic acid, larazotide acetate) is a synthetic eight amino acid peptide that functions as a tight junction regulator and reverses leaky junctions to their normally...
From €80.50 *
Details
OVA 257-268 (H-2 Kb) OVA 257-268 (H-2 Kb)
SIIVFEKL is a linear peptidic epitope, tested in T cell assays and MHC ligand assay.
From €57.50 *
Details
B8R 20-27 (H-2 Kb) B8R 20-27 (H-2 Kb)
This is amino acids 20 to 27 fragment of B8R, a vaccinia virus (VV) gene that encodes a secreted protein related to gamma interferon receptor (IFN-?). B8R binding to IFN-? neutralizes its antiviral activity.
From €57.50 *
Details
HPV E6 29-38 (HLA-A*02:01) HPV E6 29-38 (HLA-A*02:01)
TIHDIILECV is a linear peptidic epitope (epitope ID64320) studied as part of Protein E6 from Alphapapillomavirus 9. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
From €57.50 *
Details
HCV NS5B 2594-2602 (HLA-A*02:01) HCV NS5B 2594-2602 (HLA-A*02:01)
ALYDVVTKL is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus.
From €57.50 *
Details
HCMV IE-1 378-389 (HLA-B18) HCMV IE-1 378-389 (HLA-B18)
HLA-B18-restricted epitope from Cytomegalovirus (378-389)
From €92.00 *
Details
EBV LMP-2 426-434 (HLA-A*02:01) EBV LMP-2 426-434 (HLA-A*02:01)
EBV LMP-2 426-434 (HLA-A*02:01) CLGGLLTMV for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €57.50 *
Details
EBV EBNA-1 407-417 (HLA-B*35:01) EBV EBNA-1 407-417 (HLA-B*35:01)
Antigen Peptide EBV EBNA-1 407-417 (HLA-B*35:01) HPVGEADYFEY for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. HPVGEADYFEY for stimulation of human EBV EBNA-1-specific...
From €57.50 *
Details
PRAME 425-433 (HLA-A*02:01) PRAME 425-433 (HLA-A*02:01)
#
From €57.50 *
Details
HCMVlfl HCMVlfl
VMAPRTLFL is a linear peptidic epitope (epitope ID99045) studied as part of HLA class I histocompatibility antigen, alpha chain G from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays,...
From €57.50 *
Details
MOG-Peptid 35-55 MOG-Peptid 35-55
Myelin oligodendrocyte glycoprotein (MOG)35-55, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
CRGDS CRGDS
GRGDS forms the cell-binding domain of a glycoprotein, Osteopontin (OPN) . Although the native form of OPN is active in cell attachment assays, it has been observed that thrombin cleavage of OPN causes substantial enhancement of it's...
From €57.50 *
Details
HIV-1 RT 476-484 (HLA-A*02:01) HIV-1 RT 476-484 (HLA-A*02:01)
ILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*0201) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised...
From €57.50 *
Details
NS2A 4–13 (HLA-C*03:04) NS2A 4–13 (HLA-C*03:04)
#
From €57.50 *
Details
LCMV gp 276-286 (H-2 Db) LCMV gp 276-286 (H-2 Db)
SGVENPGGYCL (H-2 Db) is a single peptide for stimulation of T cells. The peptide from lymphocytic choreomeningitis virus (LCMV) glycoprotein (gp) is synthesized as it is presented by the MHC class I H-2 Db allele and can be used for...
From €57.50 *
Details
HCV Polyprotein 1406-1415 (HLA-A*02:01) HCV Polyprotein 1406-1415 (HLA-A*02:01)
KLVALGINAV is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus. Single peptide (KLVALGINAV) for stimulation of human HCV NS3 (1406-1415)-specific CD8+ T cells. The peptide is synthesised as it is...
From €57.50 *
Details
PPI 2-10 (HLA-A*02:01) PPI 2-10 (HLA-A*02:01)
ALWMRLLPL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from preproinsulin (PPI) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and...
From €57.50 *
Details
ADV Hexon 917-925 (HLA-A*02:01) ADV Hexon 917-925 (HLA-A*02:01)
Single peptide (YVLFEVFDV) for stimulation of human ADV Hexon (917-925)-specific CD8+ T cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. Lyophilized powder. Purity > 95 %, endotoxin free.
From €57.50 *
Details
Survivin 5-14 (HLA-A*0201) Survivin 5-14 (HLA-A*0201)
Single peptide (TLPPAWQPFL) for stimulation of human Survivin (5-14)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele.
From €57.50 *
Details
Cyclin A1 227-235 (HLA-A*02:01) Cyclin A1 227-235 (HLA-A*02:01)
FLDRFLSCM (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from Cyclin A1 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of...
From €57.50 *
Details
HCMV pp65-265-275(HLA-B*07:02) HCMV pp65-265-275(HLA-B*07:02)
RPHERNGFTVL is a linear peptidic epitope (epitope ID55170) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC...
From €57.50 *
Details
CD79b 52-60 (HLA-A*0201) CD79b 52-60 (HLA-A*0201)
Antigen Peptide CD antigen HLA-A*0203 (TLKDGIIMI) for stimulation of antigen-specific T cells in T cell assays
From €57.50 *
Details
SARS-CoV-2 NCAP A2 (N223-231) SARS-CoV-2 NCAP A2 (N223-231)
SARS-CoV-2 peptide LLLDRLNQL (HLA-A*0201) for stimulation of T-cells. Single peptide (LLLDRLNQL) for stimulation of human SARS-CoV-2-specific CD8+ T-cells.
From €57.50 *
Details
UTA2-1 248-256 (HLA-A*02:01) UTA2-1 248-256 (HLA-A*02:01)
Antigene peptide for stimulation of human UTA2-1(248-256)-specific CD8+T cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele.
From €57.50 *
Details
FAP 735-744 (HLA-A*02:01) FAP 735-744 (HLA-A*02:01)
GLSGLSTNHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from fibroblast activation protein (FAP) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro...
From €57.50 *
Details
Fibromodulin F3 250-259 (HLA-A*02:01) Fibromodulin F3 250-259 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (YMEHNNVYTV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €57.50 *
Details
Fibromodulin F2 206-215 (HLA-A*02:01) Fibromodulin F2 206-215 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (YLQHNEIQEV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €57.50 *
Details
Fibromodulin F1 7-17 (HLA-A*02:01) Fibromodulin F1 7-17 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (LLLAGLFSL) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €57.50 *
Details
HsPSMA 634-642 (H-2 Db) HsPSMA 634-642 (H-2 Db)
SAVKNFTEI (H-2 Db) is a single peptide for stimulation of T cells. The peptide from HsPSMA is synthesized as it is presented by the MHC class I H-2 Db allele and can be used for targeted in vitro generation and expansion of...
From €57.50 *
Details
MAGE 212-220 (HLA-C*07:01) MAGE 212-220 (HLA-C*07:01)
This Peptide MAGE HLA-C*07:01 (EGDCAPEEK) is for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €57.50 *
Details
HCMV pp65 (HLA-C*04:01) HCMV pp65 (HLA-C*04:01)
QYDPVAALFL (HLA-A*2402) is a single peptide for stimulation of T cells. The peptide from human cytomegalovirus (CMV) phosphoprotein (pp65) is synthesized as it is presented by the MHC class I HLA-A*2402 allele and can be used for...
From €57.50 *
Details
EBV BZLF-1 190-197 (HLA-B*08:01) EBV BZLF-1 190-197 (HLA-B*08:01)
Antigen peptide RAKFKQLL for stimulation of human EBV BZLF-1(190-197)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*0801 allele. RAKFKQLL is a linear peptidic epitope (epitope ID53128)...
From €57.50 *
Details
HERV-K Gag 155-163 (HLA-A*02:01) HERV-K Gag 155-163 (HLA-A*02:01)
Antigen Peptide Gag HLA-A*0201 (VIYPETLKL) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €57.50 *
Details
HERV-K Gag 139-147 (HLA-A*02:01) HERV-K Gag 139-147 (HLA-A*02:01)
Antigen Peptide Gag HLA-A*02:01 (VMAQSTQNV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €57.50 *
Details
HERV-K Env 105-114 (HLA-A*02:01) HERV-K Env 105-114 (HLA-A*02:01)
QIFEASKAHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from human endogenous retrovirus type K (HERV-K) envelope (Env) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used...
From €57.50 *
Details
HIV p24-Gag 30-40 (HLA-B*57:01) HIV p24-Gag 30-40 (HLA-B*57:01)
KAFSPEVIPMF (HLA-B*57:01) is a single peptide for stimulation of T cells. The peptide from human immunodeficiency virus 1 (HIV-1) p24 group-specific antigen (Gag) is synthesized as it is presented by the MHC class I HLA-B*57:01 allele...
From €57.50 *
Details
HIV p24-Gag 263-272 (HLA-B*27:05) HIV p24-Gag 263-272 (HLA-B*27:05)
KRWIILGLNK is a linear peptidic epitope (epitope ID33250) studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1 and Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune...
From €57.50 *
Details
EBV EBNA-3A 603-611 (HLA-A*03:01) EBV EBNA-3A 603-611 (HLA-A*03:01)
RLRAEAQVK is a linear peptidic epitope (epitope ID54728) studied as part of Epstein-Barr nuclear antigen 3 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and...
From €57.50 *
Details
EBV LMP2 356-364 (HLA-A*02:01) EBV LMP2 356-364 (HLA-A*02:01)
Antigen Peptide EBV LMP2 HLA-A*0201 (FLYALALLL) for stimulation of human EBV LMP2(356-364)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. LYALALLL is a linear peptidic epitope...
From €57.50 *
Details
EBV EBNA-1 407-417 (HLA-B*35:01) EBV EBNA-1 407-417 (HLA-B*35:01)
HPVGEADYFEY (HLA-B*3501) is a single peptide for stimulation of T cells. The peptide from human Epstein-Barr virus' (EBV) Epstein-Barr nuclear antigen 1 (EBNA-1) is synthesized as it is presented by the MHC class I HLA-B*3501 allele and...
From €57.50 *
Details
HPV 16 E7 49-57 (H-2 Db) HPV 16 E7 49-57 (H-2 Db)
RAHYNIVTF is a linear peptidic epitope studied as part of Protein E7 from Alphapapillomavirus 9 and Other Human papillomavirus protein from Human papillomavirus. This epitope is used for immune reactivity in, T cell assays, B cell assays...
From €57.50 *
Details
Influenza A NP 366-374 (H-2 Db) Influenza A NP 366-374 (H-2 Db)
ASNENMETM (H-2 Db) is a single peptide for stimulation of T cells. The peptide from Influenza nucleoprotein is synthesized as it is presented by the MHC class I H-2 Db allele and can be used for targeted in vitro generation and expansion...
From €57.50 *
Details
CD20 188-196 (HLA-A*02:01) CD20 188-196 (HLA-A*02:01)
SLFLGILSV is a linear peptidic epitope (epitope ID140742) studied as part of B-lymphocyte antigen CD20 from Homo sapiens (human), tested in T cell assays CD20 188-196 (HLA-A*02:01) SLFLGILSV for stimulation of T-cells. Single peptide...
From €57.50 *
Details
SIV Gag 181-189 (Mamu-A*01) SIV Gag 181-189 (Mamu-A*01)
From €57.50 *
Details
Bcl-2 214-223 (HLA-A*02:01) Bcl-2 214-223 (HLA-A*02:01)
Bcl-2 peptide 214-223 (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from B cell lymphoma 2 (Bcl-2) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro...
From €57.50 *
Details
CD22 antigen (HLA-A*02:01) CD22 antigen (HLA-A*02:01)
Antigen Peptide CD antigen HLA- A*0201 (PLSEGPHSL) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays
From €57.50 *
Details
CD22 antigen 459-467 (HLA-A*02:01) CD22 antigen 459-467 (HLA-A*02:01)
D22 antigen(459-467) peptide SLPYHSQKL (HLA- A*02:01) for stimulation of T-cells. Single peptide (SLPYHSQKL) for stimulation of human CD22 antigen(459-467)-specific CD8+ T-cells.
From €57.50 *
Details
Influenza A PB1 591-599 (HLA-A*01:01) Influenza A PB1 591-599 (HLA-A*01:01)
VSDGGPNLY is a linear peptidic epitope (epitope ID70898) studied as part of RNA-directed RNA polymerase catalytic subunit from Influenza A virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand...
From €57.50 *
Details
CD22 antigen 173-181 (HLA-A*02:01) CD22 antigen 173-181 (HLA-A*02:01)
CD22 antigen (173-181) peptide QLQWLLEGV (HLA- A*0201) for stimulation of T-cells. Single peptide (QLQWLLEGV) for stimulation of human CD22 antigen(173-181)-specific CD8+ T-cells.
From €57.50 *
Details
ADV hexon (HLA-B*35:01) ADV hexon (HLA-B*35:01)
ADV hexon peptide MPNRPNYIAF (HLA-B*35:01) for stimulation of T-cells. Single peptide (MPNRPNYIAF) for stimulation of human ADV hexon-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*35:01 allele
From €57.50 *
Details
ADV hexon (HLA-B*07:02) ADV hexon (HLA-B*07:02)
ADV hexon peptide KPYSGTAYNAL (HLA-B*07:02) for stimulation of T-cells. Single peptide (KPYSGTAYNAL) for stimulation of human ADV hexon-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*07:02...
From €57.50 *
Details
ADV hexon (HLA-A*24:02) ADV hexon (HLA-A*24:02)
ADV hexon peptide TYFSLNNKF (HLA-A*24:02) for stimulation of T-cells. Single peptide (TYFSLNNKF) for stimulation of human ADV hexon-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class IHLA-A*24:02 allele
From €57.50 *
Details
CEA 605-613 (HLA-A*02:01) CEA 605-613 (HLA-A*02:01)
CEA 605-613 peptide YLSGANLNL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from Adenylyl Cyclase-Associated Protein 1 (CAP1) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be...
From €57.50 *
Details
OVA-Q4H7(H-2 Kb) OVA-Q4H7(H-2 Kb)
Q4H7 peptide SIIQFEHL (H-2 Kb) for stimulation of T cells. Single peptide (SIIQFEHL) for stimulation of mouse Ovalbumin-specific CD8+ T cells. The peptide from Ovalbumin (OVA) variant Q4H7 is synthesized as it is presented by the MHC...
From €57.50 *
Details
Uty (H-2 Db) Uty (H-2 Db)
Antigen peptide WMHHNMLDI for stimulation of murine Uty-specific CD8+T-cells. The peptide is synthesised as it is presented by the MHC class I H-2 Db allele.
From €57.50 *
Details
MAGE-A1 161-169 (HLA-A*01:01) MAGE-A1 161-169 (HLA-A*01:01)
EADPTGHSY is a linear peptidic epitope (epitope ID11010) studied as part of Melanoma-associated antigen 1 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
From €57.50 *
Details
HIV gag 197-205 (H-2 Kd) HIV gag 197-205 (H-2 Kd)
HIV gag peptide AMQMLKETI (H-2 Kd) is a single peptide for stimulation of T cells. The peptide from human immunodeficiency virus (HIV) group-specific antigen (Gag) is synthesized as it is presented by the MHC class I H-2 Kd allele and...
From €57.50 *
Details
Survivin 95-104 (HLA-A*02:01) Survivin 95-104 (HLA-A*02:01)
Survivin-derived peptide of ELTLGEFLKL sequence covering 95–104 and A*0201 molecule.Single peptide (ELTLGEFLKL) for stimulation of human Survivin -specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I...
From €57.50 *
Details
WT1 235-243 (HLA-A*24:02) WT1 235-243 (HLA-A*24:02)
Antigen peptide WT1 235-243 (HLA-A*24:02) CMTWNQMNL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €57.50 *
Details
gp100 280-288 (HLA-A*02:01) gp100 280-288 (HLA-A*02:01)
YLEPGPVTA is a linear peptidic epitope studied as part of Melanocyte protein PMEL from Homo sapiens (human). gp100 peptide YLEPGPVTA (HLA-A*02:01) for stimulation of human gp100-specific CD8+ T-cells. The peptide is synthesised as it is...
From €57.50 *
Details
MUC1 (HLA-B*07:02) MUC1 (HLA-B*07:02)
MUC1 peptide VPGWGIALL (HLA-B*07:02) is a single peptide for stimulation of T cells. The peptide from Mucin 1 (MUC1) is synthesized as it is presented by the MHC class I HLA-B*0702 allele and can be used for stimulation of...
From €57.50 *
Details
MUC1 (HLA-A*02:01) MUC1 (HLA-A*02:01)
Antigen Peptide Mucin-1 HLA-A*0201 for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. MUC1 peptide STAPPVHNV (HLA-A*0201) is a single peptide for stimulation of T cells....
From €57.50 *
Details
WT1 (HLA-A*02:01) WT1 (HLA-A*02:01)
RMFPNAPYL is a linear peptidic epitope (epitope ID54882) studied as part of Wilms tumor protein from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays WT-1 126-134...
From €57.50 *
Details
HM1.24-aa 126-134 (HLA-A*02:01) HM1.24-aa 126-134 (HLA-A*02:01)
KLQDASAEV is a linear peptidic epitope (epitope ID455519) studied as part of Bone marrow stromal antigen 2 from Homo sapiens (human), tested in MHC ligand assays. HM1.24 126-134 (HLA-A*02:01) KLQDASAEV for stimulation of T-cells. Single...
From €57.50 *
Details
HA-1 137-145 (HLA-A*02:01) His139 HA-1 137-145 (HLA-A*02:01) His139
Antigen Peptide HA-1 137-145 His139 (HLA-A*02:01) VLHDDLLEA for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. VLHDDLLEA is a linear peptidic epitope (epitope ID136896)...
From €57.50 *
Details
LLO 91-99 (H-2 Kd) LLO 91-99 (H-2 Kd)
This peptide is a tetramer of biotinylated peptide with streptavidin mainly composed of L. monocytogenes-derived peptide of GYKDGNEYI sequence covering 91-99 and H-2Kd molecule. The pMHC tetramer recognizes mouse CD8 T cells, and can be...
From €57.50 *
Details
NY-ESO-1 157-165 (HLA-A*02:01) NY-ESO-1 157-165 (HLA-A*02:01)
NY-ESO-1 157-165 (HLA-A*02:01) peptide SLLMWITQV for stimulation of T-cells. Single peptide SLLMWITQV for stimulation of human NY-ESO-1-specific CD8+ T-cells SLLMWITQV is a linear peptidic epitope (epitope ID59283) studied as part of...
From €57.50 *
Details
gp100 209-217 (HLA-A*02:01) gp100 209-217 (HLA-A*02:01)
ITDQVPFSV is a linear peptidic epitope studied as part of Melanocyte protein PMEL from Homo sapiens (human) and Melanocyte protein PMEL from Mus musculus (mouse). Gp 100 209-217 peptide ITDQVPFSV (HLA-A*02:01) for stimulation of T-cells....
From €57.50 *
Details
gp100 209-217 mutant (HLA-A*02:01) 210M gp100 209-217 mutant (HLA-A*02:01) 210M
gp100 209-217 Pos. 210M (HLA-A*02:01) IMDQVPFSV is a linear peptidic epitope studied as part of Melanoma antigen preferentially expressed in tumors from Homo sapiens (human). This epitope has been studied for immune reactivity in several...
From €57.50 *
Details
HER-2/neu 689-697 (HLA-A*02:01) HER-2/neu 689-697 (HLA-A*02:01)
Her-2/neu peptide RLLQETELV (HLA-A*02:01) for stimulation of T-cells. Single peptide (RLLQETELV) for stimulation of human Her-2/neu-specific CD8+ T-cells.
From €57.50 *
Details